4AB:ETR
AbbVie Common Stock
€263,20
arrow_downward
-1,13%(-3,00) 1D
18 Nov., 17:35:54 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€265,60
High
€266,70
Low
€262,40
Mkt. cap
505,56Â mjd
Avg. vol.
581,00
Volume
201,00
52-wk high
€272,20
52-wk low
€162,85
No. of employees
57Â k
Open
€265,60
High
€266,70
Low
€262,40
Mkt. cap
505,56Â mjd
Avg. vol.
581,00
Volume
201,00
52-wk high
€272,20
52-wk low
€162,85
No. of employees
57Â k
News stories
From web sources and news partners
Global Banking & Finance Review
·
40 minute gelede
AbbVie falls 2.31% in Wednesday's session
Traders Union
·
8 uur gelede
AbbVie stock weekly forecast: Holds gains as buyers stay in control
Investing.com
·
9 uur gelede
Abbvie stock price target raised to $349 by Piper Sandler on growth
The Globe and Mail
·
1 dag gelede
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57Â k
Founded10 Apr. 2012
HeadquartersNorth Chicago, Illinois, Verenigde State van Amerika
SectorHealth Care
Industry-
Websiteabbvie.com